Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

Journal of Neurosurgery

Volumn 103 PEDIATRICS, Issue SUPPL. 1, 2005, Pages 61-68

  Berger, Rachel Pardes ^a   Adelson, P David ^b   Pierce, Mary Clyde ^b   Dulani, Tina ^b   Cassidy, Laura D ^b   Kochanek, Patrick M ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

Biomarkers; Child abuse; Myelin basic protein; Neuron specific enolase; Pediatric neurosurgery; S100B; Traumatic brain injury

Indexed keywords

MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B; BIOLOGICAL MARKER; ENOLASE; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; CHILD ABUSE; COMPARATIVE STUDY; INFANT; INJURY SCALE; NEWBORN; PRESCHOOL CHILD;

BIOLOGICAL MARKERS; BRAIN INJURIES; CASE-CONTROL STUDIES; CHILD; CHILD ABUSE; CHILD, PRESCHOOL; FEMALE; GLASGOW COMA SCALE; HUMANS; INFANT; INFANT, NEWBORN; INJURY SEVERITY SCORE; MALE; MYELIN BASIC PROTEINS; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PROSPECTIVE STUDIES; S100 PROTEINS;

EID: 26044445222     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/ped.2005.103.1.0061     Document Type: Article

References (55)

1. Akhtar JI, Spear RM, Senac MO, Peterson BM, Diaz SM: Detection of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain. Pediatr Crit Care Med 4:322-326, 2003
2. Anderson RE, Hansson LO, Liska J, Settergren G, Vaage J: The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg 69:847-850, 2000
3. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G: High serum S100B levels for trauma patients without head injuries. Neurosurgery 48:1255-1260, 2001
4. Anderson RE, Hansson LO, Nilsson O, Liska J, Settergren G, Vaage J: Increase in serum S100A1-b and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 71:1512-1517, 2001
5. Barlow KM, Minns RA: Annual incidence of shaken impact syndrome in young children. Lancet 356:1571-1572, 2000
6. Beers SR, Berger RP, Skold A, Adelson PD: Neurocognitive outcome and relationship to serum markers in infants and young children following inflicted vs. noninflicted traumatic brain injury. Pediatr Res 55:70A, 2004 (Abstract)
7. Bell MJ, Kochanek PM, Heyes MP, Wisniewski SR, Sinz EH, Clark RS, et al: Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med 27:493-497, 1999
8. Berger R: Biomarkers or neuroimaging in central nervous system injury: will the real "gold standard" please stand up? Pediatr Crit Care Med 4:391-392, 2003
9. Berger RP, Dulani T, Brown D, Adelson P, Pitetti R, Kochanek P: Measurement of biomarkers of brain injury in infants at increased risk of inflicted traumatic brain injury. Pediatr Res 55:233A, 2004 (Abstract)
10. Billmire ME, Myers PA: Serious head injury in infants: accident or abuse? Pediatrics 75:340-342, 1985
11. DeGiorgio CM, Correale JD, Gott PS, Ginsburg DL, Bracht KA, Smith T, et al: Serum neuron-specific enolase in human status epilepticus. Neurology 45:1134-1137, 1995
12. Duhaime AC, Alario AJ, Lewander WJ, Schut L, Sutton LN, Seidl TS, et al: Head injury in very young children: mechanisms, injury types, and ophthalmologic findings in 100 hospitalized patients younger than 2 years of age. Pediatrics 90:179-185, 1992
13. Duhaime AC, Christian CW, Rorke LB, Zimmerman RA: Nonaccidental head injury in infants - the "shaken-baby syndrome." N Engl J Med 338:1822-1829, 1998
14. Duhaime AC, Partington MD: Overview and clinical presentation of inflicted head injury in infants. Neurosurg Clin N Am 13:149-154, 2002
15. Durham SR, Clancy RR, Leuthardt E, Sun P, Kamerling S, Dominguez T, et al: CHOP Infant Coma Scale ("Infant Face Scale"): a novel coma scale for children less than two years of age. J Neurotrauma 17:729-737, 2000
16. Ettaro L, Berger RP, Songer T: Abusive head trauma in young children: characteristics and medical charges in a hospitalized population. Child Abuse Negl 28:1099-1111, 2004
17. Ewing-Cobbs L, Kramer L, Prasad M, Canales DN, Louis PT, Fletcher JM, et al: Neuroimaging, physical, and developmental findings after inflicted and noninflicted traumatic brain injury in young children. Pediatrics 102:300-307, 1998
18. Ewing-Cobbs L, Prasad M, Kramer L, Landry S: Inflicted traumatic brain injury: relationship of developmental outcome to severity of injury. Pediatr Neurosurg 31:251-258, 1999
19. Fridriksson T, Kini N, Walsh-Kelly C, Hennes H: Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study. Acad Emerg Med 7:816-820, 2000
20. Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, et al: Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin Chem 49:967-970, 2003
21. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al: Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327:588-593, 1992
22. Hahn YS, Chyung C, Barthel MJ, Bailes J, Flannery AM, McLone DG: Head injuries in children under 36 months of age. Demography and outcome. Childs Nerv Syst 4:34-40, 1988
23. Haviland J, Russell RI: Outcome after severe non-accidental head injury. Arch Dis Child 77:504-507, 1997
24. Ingebrigtsen T, Romner B: Biochemical serum markers of traumatic brain injury. J Trauma 52:798-808, 2002
25. Ingebrigtsen T, Romner B: Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report. J Neurosurg 85:945-948, 1996
26. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B: Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 45:468-476, 1999
27. Jayawant S, Rawlinson A, Gibbon F, Price J, Schulte J, Sharples P, et al: Subdural haemorrhages in infants: population based study. BMJ 317:1558-1561, 1998
28. Jenny C, Hymel KP, Ritzen A, Reinert SE, Hay TC: Analysis of missed cases of abusive head trauma. JAMA 281:621-626, 1999
29. Jimi T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi Y, et al: High levels of nervous system specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 211:37-46, 1992
30. Keenan HT, Runyan DK, Marshall SW, Nocera MA, Merten DF, Sinal SH: A population-based study of inflicted traumatic brain injury in young children. JAMA 290:621-626, 2003
31. Kochanek PM, Berger RP, Jenkins LW: Biochemical and molecular mechanisms after severe traumatic brain injury in children, in Vincent JL (ed): Yearbook of Intensive Care and Emergency Medicine, 2002. Berlin: Springer-Verlag, 2002, pp 688-698
32. Marshall LF, Becker DP, Bowers SA, Cayard C, Eisenberg H, Gross CR, et al: The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neurosurg 59:276-284, 1983
33. McKeating EG, Andrews PJ, Mascia L: Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl 71:117-179, 1998
34. Morad Y, Kim YM, Mian M, Huyer D, Capra L, Levin AV: Nonophthalmologist accuracy in diagnosing retinal hemorrhages in the shaken baby syndrome. J Pediatr 142:431-434, 2003
35. Morris MW, Smith S, Cressman J, Ancheta J: Evaluation of infants with subdural hematoma who lack external evidence of abuse. Pediatrics 105:549-553, 2000
36. Mukherjee A, Vogt RF, Linthicum DS: Measurement of myelin basic protein by radioimmunoassay in closed head trauma, multiple sclerosis and other neurological diseases. Clin Biochem 18:304-307, 1985
37. Noseworthy TW, Anderson BJ, Noseworthy AF, Shustack A, Johnston RG, Petruk KC, et al: Cerebrospinal fluid myelin basic protein as a prognostic marker in patients with head injury. Crit Care Med 13:743-746, 1985
38. O'Neill JA Jr, Meacham WF, Griffin JP, Sawyer JL: Patterns of injury in the battered child syndrome. J Trauma 13:332-339, 1973
39. Pitetti RD, Maffei F, Chang K, Hickey R, Berger R, Pierce MC: Prevalence of retinal hemorrhages and child abuse in children who present with an apparent life-threatening event. Pediatrics 110:557-562, 2002
40. Portela LV, Tort AB, Schaf DV, Ribeiro L, Nora DB, Walz R, et al: The serum S100B concentration is age dependent. Clin Chem 48:950-952, 2002
41. Prasad MR, Ewing-Cobbs L, Swank PR, Kramer L: Predictors of outcome following traumatic brain injury in young children. Pediatr Neurosurg 36:64-74, 2002
42. Raabe A: High serum S100B levels for trauma patients without head injuries. Neurosurgery 49:1491-1493, 2001
43. Raabe A, Grolms C, Seifert V: Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg 13:56-59, 1999
44. Romner B, Ingebrigtsen T: High serum S100B levels for trauma patients without head injuries. Neurosurgery 49:1490-1493, 2001 (Letter)
45. Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE: Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 17:641-647, 2000
46. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ: Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10:471-476, 1996
47. Ruppel RA, Kochanek PM, Adelson PD, Rose ME, Wisniewski SR, Bell MJ, et al: Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. J Pediatr 138:18-25, 2001
48. Skogseid IM, Nordby HK, Urdal P, Paus E, Lilleaas F: Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir (Wien) 115:106-111, 1992
49. Spinella PC, Dominguez T, Drott HR, Huh J, McCormick L, Rajendra A, et al: S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 31:939-945, 2003
50. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-84, 1974
51. Thomas DG, Hoyle NR, Seeldrayers P: Myelin basic protein immunoreactivity in serum of neurosurgical patients. J Neurol Neurosurg Psychiatry 47:173-175, 1984
52. Thomas DG, Palfreyman JW, Ratcliffe JG: Serum-myelinbasic-protein assay in diagnosis and prognosis of patients with head injury. Lancet 1:113-115, 1978
53. Van de Pol M, Twijnstra A, ten Velde GP, Menheere PP: Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma. J Neurooncol 19:149-154, 1994
54. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, et al: Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62:1303-1310, 2004
55. Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T: Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43:267-271, 1995